Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costsShow others and affiliations
2012 (English)In: Pharmacogenomics (London), ISSN 1462-2416, E-ISSN 1744-8042, Vol. 13, no 12, p. 1405-1417Article, review/survey (Refereed) Published
Abstract [en]
Genotyping patients for CYP2C9 and VKORC1 polymorphisms can improve the accuracy of dosing during the initiation of anticoagulation with vitamin K antagonists (coumarin derivatives). The anticipated degree of improvement in the safety of anticoagulation with coumarins through genotyping may vary depending on the quality of patient care, which varies both with and among countries. The management and the cost of anticoagulant care can therefore influence the cost effectiveness of genotyping within any given country. In this article, we provide an overview of the cost effectiveness of pharmacogenetics-guided dosing of coumarin derivatives. We describe the organization of anticoagulant care in the UK, Sweden, The Netherlands, Greece, Germany and Austria, where a genotype-guided dosing algorithm is currently being investigated as part of the EU-PACT trial. We also explore the costs of anticoagulant care for the treatment of atrial fibrillation in these countries.
Place, publisher, year, edition, pages
Future Medicine , 2012. Vol. 13, no 12, p. 1405-1417
Keywords [en]
acenocoumarol, atrial fibrillation, cost analysis, coumarins, health, economics, healthcare system, phenprocoumon, warfarin
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-84904DOI: 10.2217/PGS.12.124ISI: 000308776100016OAI: oai:DiVA.org:liu-84904DiVA, id: diva2:562915
Note
Funding Agencies|EU|HEALTH-F2-2009-223062|Netherlands Organisation for Health Research and Development (ZonMW)||Dutch Health Care Insurance Board (CVZ)||Royal Dutch Pharmacists Association (KNMP)||private public funded Top Institute Pharma||EU Innovative Medicines Initiative (IMI)||FP7||Dutch Medicines Evaluation Board||Dutch Ministry of Health and industry||
2012-10-262012-10-262017-12-07